Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Filomena Panzone"'
Autor:
Isabella Testa, Elena Verzoni, Paolo Grassi, Maurizio Colecchia, Filomena Panzone, Giuseppe Procopio
Publikováno v:
Rare Tumors, Vol 6, Iss 4 (2014)
We report the case of a young woman diagnosed with metastatic urachal carcinoma. A multimodal approach was used for the management of this patient. Due to disease progression despite surgery and two different chemotherapy regimens (neoadjuvant capeci
Externí odkaz:
https://doaj.org/article/1f4b1902e2cc4137acb9f43b1d5c98c3
Autor:
Antonio Rossi, Francesca Casaluce, Assunta Sgambato, Fortunato Ciardiello, Filomena Panzone, Paola Claudia Sacco, Cesare Gridelli, Paolo Maione
Publikováno v:
Expert Opinion on Pharmacotherapy. 14:2019-2031
Small cell lung cancer (SCLC) is a rapidly progressive disease that accounts for approximately 15% of all lung cancers. Chemotherapy remains the cornerstone of treatment of SCLC, but in the last two decades, its progress has reached a plateau. Althou
Autor:
Clelia Madeddu, Antonio Macciò, Giorgio Astara, Elena Massa, Mariele Dessì, Giorgia Antoni, Filomena Panzone, Roberto Serpe, Giovanni Mantovani
Publikováno v:
Mediterranean Journal of Nutrition and Metabolism. 3:165-172
Publikováno v:
Expert Opinion on Pharmacotherapy. 10:1359-1366
Medroxyprogesterone acetate (MPA) is a synthetic, orally active derivative of the natural steroid hormone progesterone, widely used in oncology both in the endocrine treatment of hormone-related cancers and as supportive therapy in the cachexia syndr
Autor:
Elena Massa, Roberto Serpe, Francesca Maria Tanca, Clelia Madeddu, Giorgio Astara, Antonio Macciò, Filomena Panzone, Giorgia Antoni, Giovanni Mantovani
Publikováno v:
Mediterranean Journal of Nutrition and Metabolism. 2:29-36
Cancer-related anorexia/cachexia syndrome (CACS) is a multifactorial syndrome characterised by tissue wasting, particularly lean body mass (LBM), metabolic alterations, fatigue, anorexia and reduced food intake. In April 2005 we started a phase III r
Autor:
Elena Verzoni, Giuseppe Procopio, Maurizio Colecchia, Filomena Panzone, Paolo Grassi, Isabella Testa
Publikováno v:
Rare Tumors, Vol 6, Iss 4 (2014)
Rare Tumors
Rare Tumors
We report the case of a young woman diagnosed with metastatic urachal carcinoma. A multimodal approach was used for the management of this patient. Due to disease progression despite surgery and two different chemotherapy regimens (neoadjuvant capeci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06a929015fefd0245d9501904b0901bd
Autor:
Roberto Serpe, M.C. Cau, Clelia Madeddu, Filomena Panzone, Giorgio Astara, L. Montaldo, Mariele Dessì, Marco Mura, Antonio Macciò, Giorgia Antoni, Giovanni Mantovani, Francesca Maria Tanca, Quirico Mela
Publikováno v:
Clinical nutrition (Edinburgh, Scotland). 31(2)
Summary Background & aims A phase III, randomized non-inferiority study was carried out to compare a two-drug combination (including nutraceuticals, i.e. antioxidants) with carnitine + celecoxib ± megestrol acetate for the treatment of cancer-relate
Autor:
Antonio, Macciò, Clelia, Madeddu, Paola, Chessa, Filomena, Panzone, Paolo, Lissoni, Giovanni, Mantovani
Publikováno v:
In vivo (Athens, Greece). 24(2)
It has been shown that the neurohypophyseal peptide oxytocin is present in the human thymus and in vitro it can mimic interleukin (IL)-2 action in the induction of interferon-gamma production. In the present study, we tested the capacity of oxytocin
Autor:
Antonio Macciò, Roberto Serpe, Filomena Panzone, Giovanni Mantovani, Mariele Dessì, Paolo Contu, Clelia Madeddu, Elena Massa
Purpose.A phase III, randomized study was carried out to establish the most effective and safest treatment to improve the primary endpoints of cancer cachexia—lean body mass (LBM), resting energy expenditure (REE), and fatigue—and relevant second
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06b0a002eb84d056c1da3a0f274592b7
https://europepmc.org/articles/PMC3227938/
https://europepmc.org/articles/PMC3227938/
Autor:
Clelia Madeddu, Roberto Serpe, Mariele Dessì, Elena Massa, Filomena Panzone, Giovanni Mantovani, Giorgia Antoni, Antonio Macciò
Publikováno v:
Journal of molecular medicine (Berlin, Germany). 88(1)
Chronic inflammation is one of the main features of cancer cachexia. Experimental and clinical studies showed that cyclooxygenase-2 inhibitors, such as celecoxib, may be beneficial in counteracting major symptoms of this devastating syndrome. We carr